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Abstract 
Balloon aortic valvuloplasty is often used as a palliative measure or as a bridge to 
transcatheter aortic valve replacement in the management of aortic stenosis in high 
risk or inoperable patients. Severe aortic stenosis coexisting with coronary artery 
disease is not uncommon. In these circumstances, adjuvant percutaneous coronary 
intervention may be warranted. The safety and efficacy of combined valve and coro-
nary intervention strategies has been recently studied. An increased incidence of 
complications when both procedures are performed in the same setting may throw 
new challenges. We report a case of fatal acute stent thrombosis following balloon 
aortic valvuloplasty and percutaneous coronary intervention. 
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1. Introduction 
Coronary occlusion is a relatively rare complication of balloon aortic valvuloplasty 
(BAV) with an occurrence rate of 0.66 percent [1]. The presence of significant coronary 
artery disease in patients with aortic stenosis has brought about a necessity for com-
bined BAV and percutaneous coronary intervention (PCI) techniques in nonsurgical 
patients. Herein, we describe the first case of acute stent thrombosis due to the com-
bined coronary and valve intervention (CVI). 
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2. Case Report 
A 80-year-old woman presented to the hospital with progressive angina and dyspnea 
on exertion. Her relevant past history included known severe aortic stenosis, diabetes 
mellitus, dyslipidemia chronic kidney disease and paroxysmal atrial fibrillation. An 
echocardiogram revealed severe aortic stenosis with peak to mean gradient of 74/41 
mm Hg, left ventricular ejection fraction of 60%. Diagnostic cardiac catheterization 
showed severe 90% stenosis of mid segment of the left anterior descending artery 
(LAD) followed by 70% diffuse stenosis (Figure 1). The rest of the coronaries has no 
significant obstructive disease. 
The patient was evaluated by the cardio-thoracic surgical team and deemed unsuita-
ble for surgical valve replacement because of multiple comorbidities and high surgical 
risk. She was brought to the cardiac catheterization lab. A signed informed consent was 
obtained from the patient’s family.9F arterial access and 7F venous access was obtained 
via the right femoral artery and vein respectively. Decision was made to perform PCI to 
the LAD followed by BAV. The patient was already on Aspirin, did not receive any pre 
procedural Clopidogrel. She was given 0.75 mg/kg Bivalirudin bolus followed by 1.75 
mg/kg/hr infusion. A 6F guiding catheter (XB3, Cordis, NJ) was used for the percuta-
neous intervention. The lesion was pre-dilated with 2.5 × 12 mm balloon (Voyager, 
Abbott Vascular, CA) at a pressure of 12 atms. Then, the residual lesion was covered 
with three bare metal stents in an overlapped fashion. Stents (Vision, Abbott Vascular, 
CA) measuring 3.0 × 15 mm, 3.0 × 15 mm and 2.75 × 23 mm were deployed, proximal 
to distal, at high pressures of 16 atms. Repeat angiography revealed no residual stenosis 
in the stented segment (Figure 2). Following that, balloon valvuloplasty on the aortic 
valve using 18 × 40 mm balloon (Atlas, Bard peripheral vascular, AZ) was performed 
using the power injector and ultra dilute dye described previously by our group [2]. 
 
 
Figure 1. Coronary angiography showing severe 90% stenosis of mid segment of the left anterior 
descending artery (arrow) followed by 70% diffuse stenosis. 
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Figure 2. Coronary angiography showing no residual stenosis in the stented segment (arrow). 
 
 
Figure 3. Aortography showing 4+ aortic regurgitation, anterolateral severe hypokinesis (dotted 
line) and acute stent thrombosis of the mid anterior descending artery (arrow). 
 
Immediately, the patient experienced hypotension and sudden onset of chest pain. 
ST segment elevation (STEMI) was noted on the monitor. An IABP was rapidly in-
serted via the left common femoral arterial approach. Aortography revealed 4+ aortic 
regurgitation, anterolateral severe hypokinesis and acute stent thrombosis of the mild 
left anterior descending artery (Figure 3). Counterpulsation was discontinued. The pa-
tient was intubated and cardio pulmonary resuscitation was initiated. While doing 
CPR, angioplasty and thrombectomy was performed on the LAD. Despite re-institution 
of TIMI 2 - 3 flow in the LAD, the patient was in cardiac standstill. The team leader at 
the point decided to stop further resuscitation efforts since the patient was not a candi-
date for surgical aortic valve replacement. 
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3. Discussion 
Coexisting coronary artery disease and aortic stenosis have been recently managed with 
concomitant PCI and BAV. Ben-Dor I. and his colleagues recently studied the feasibili-
ty of this strategy in 80 patients and found out it was safe and efficacious [3]. However, 
effect of PCI in the same setting on BAV outcomes is unknown.  
Coronary occlusion is a known fatal complication of BAV. It can present as either 
late or acute myocardial infarction. Poor anticoagulation and calcium embolization 
from the aortic valve have been implicated as a possible mechanism. An additional 
mechanism could be transient left ventricular occlusion during valvuloplasty resulting 
in brief coronary vasoconstriction due to acute spikes in vasopressin [4]. We report the 
first case of acute stent thrombosis following combined BAV and PCI. In our case, the 
most likely reason of acute stent thrombosis is acute aortic regurgitation leading to hy-
potension and elevated left ventricular end diastolic pressure compromising coronary 
perfusion. This is in combination with lack of Clopidogrel preloading in the setting of 
Bivalirudin. 
The advantage of adjunct PCI before BAV is theoretical as performing PCI will help 
to alleviate ischemia prior to rapid ventricular pacing and BAV. In our particular case, 
there was a fatal outcome since it contributed to the acute aortic regurgitation thus 
compromising hemodynamics, resulting in acute stent thrombosis. Our experience has 
influenced us to stage BAV and PCI unless there is a compelling reason to perform 
them in combination. 
4. Conclusion 
This case has altered our approach to intervention with concomitant coronary artery 
disease and severe aortic stenosis. We believe staging intervention may improve out-
comes. Further investigations may be warranted. 
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Abbreviations 
BAV = Balloon Aortic Valvuloplasty,  
PCI = Percutaneous Coronary Intervention,  
CVI = Coronary and Valve Intervention,  
LAD = Left Anterior Descending,  
STEMI = ST Elevation Myocardial Infarction,  
IABP = Intra Aortic Balloon Pump,  
CPR = Cardio Pulmonary Resuscitation. 
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